These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 555410)

  • 21. [Clinico-immunological studies of pulmonary tuberculosis in the elderly].
    Harada S; Takamoto M; Harada Y; Ninomiya H; Maruyama M; Ishibashi T; Shinoda A
    Kekkaku; 1989 Aug; 64(8):529-36. PubMed ID: 2811010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Remote results of treatment and functional state of the cardio-vascular and respiratory systems in patients with pulmonary tuberculosis of middle and old age].
    Iashchenko BP; Marchuk AI
    Vrach Delo; 1967 May; 5():79-83. PubMed ID: 5618550
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis].
    Naubet'iarova AN; Syzdykova NS; Alenova AKh
    Probl Tuberk; 1987; (4):34-6. PubMed ID: 3110764
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 25. [State of immunity in patients with destructive infiltrative pulmonary tuberculosis after effective and ineffective therapy].
    Pakhomov AM
    Probl Tuberk; 1983 Sep; (9):23-6. PubMed ID: 6647440
    [No Abstract]   [Full Text] [Related]  

  • 26. Adreno-cortical reserve in pulmonary tuberculosis.
    Behera D; Dash RJ
    J Assoc Physicians India; 1992 Aug; 40(8):520-1. PubMed ID: 1339211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Observation on ambulant chemotherapy for primary treated cases of pulmonary tuberculosis (author's transl)].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):201-3. PubMed ID: 555426
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)].
    Urakami E; Nagasawa S
    Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bronchial carcinoma and pulmonary tuberculosis (author's transl)].
    Kohout J
    Prax Klin Pneumol; 1977 Jul; 31(7):671-5. PubMed ID: 896634
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of multi resistant pulmonary tuberculosis with rifampin (author's transl)].
    Mena G; Carrasco E; Velasco J; Valenzuela P; Busel I
    Rev Med Chil; 1974 Oct; 102(10):798-803. PubMed ID: 4458021
    [No Abstract]   [Full Text] [Related]  

  • 31. [Background factors of intractable pulmonary tuberculosis patients--Immunological approach (author's transl)].
    Shima K
    Kekkaku; 1979 Dec; 54(12):592-4. PubMed ID: 522361
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical study of tuberactinomycin-N in pulmonary tuberculosis (author's transl)].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1973 Oct; 48(10):473-9. PubMed ID: 4780239
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
    Kitatani F; Fujimoto S; Asahi T; Konishiike J; Sera Y
    Kekkaku; 1974 May; 49(5):133-8. PubMed ID: 4408937
    [No Abstract]   [Full Text] [Related]  

  • 34. [NK cell activity in pulmonary tuberculosis (author's transl)].
    Yoneda T; Ishibashi J; Nishikawa K; Mikami R; Kasai M; Tokunaga T
    Kekkaku; 1982 Apr; 57(4):233-7. PubMed ID: 7109422
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study of enviomycin (EVM) in pulmonary tuberculosis (author's transl)].
    Kuramitsu I; Ando K; Ito N; Kishimoto K; Murase Y; Matsumura H; Matsui O; Miki S; Ito T; Yanagawa T; Tanaka S; Sakai M; Takeuchi J; Yamamoto Y; Suzuki S; Sata K; Ohbori K; Horie E; Sakurai K; Mori T; Nagami T; Adachi S; Oda T; Yamaguchi K; Takehisa R
    Kekkaku; 1978 Apr; 53(4):269-73. PubMed ID: 661060
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on pulmonary function in patients with pulmonary tuberculosis--with special reference to flow-volume curve and closing volume, and their relation with various factors (author's transl)].
    Hiroi K
    Kekkaku; 1978 Jan; 53(1):49-63. PubMed ID: 633700
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of corticosteroid hormones and pyrogenal on the humoral factors of natural immunity in pulmonary tuberculosis].
    Mezhebovskiĭ VR
    Probl Tuberk; 1981 Jun; (6):25-8. PubMed ID: 7279903
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberactinomycin-N (enviomycin-EVM) in the treatment of pulmonary tuberculosis (author's transl)].
    Ishikawa H; Nakashima N; Okada H; Tsutsumi T; Ishizaki T; Oka R; Oda T; Shigeno Y; Yamaguchi K; Nakatomi M; Hara K
    Kekkaku; 1981 Jul; 56(7):369-74. PubMed ID: 6276611
    [No Abstract]   [Full Text] [Related]  

  • 39. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adrenal cortex function at different stages of surgical intervention in pulmonary tuberculosis].
    Matiushina ZV
    Probl Tuberk; 1976; 3():39-43. PubMed ID: 967854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.